Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HBB | P68871 | 1/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4659475 | 0.97 | PIK3CD (0.59) | PIK3CDCA12CA2CA3CA4 | |
| SCHEMBL12455820 | 0.91 | PIK3CD (0.54) | PIK3CDCA12CA2CA3CA4 | |
| SCHEMBL10143907 | 0.88 | CA12 (0.61) | PIK3CDCA12CA2CA3CA4 | |
| SCHEMBL735129 | 0.88 | — | — | |
| SCHEMBL9025471 | 0.88 | PIK3CD (0.52) | PIK3CDCA12CA2CA3CA4 | |
| SCHEMBL23430877 | 0.86 | — | — | |
| SCHEMBL6167401 | 0.86 | — | — | |
| SCHEMBL13852514 | 0.86 | — | — | |
| SCHEMBL22503168 | 0.86 | PIK3CD (0.50) | PIK3CDCA12CA2CA3CA4 | |
| SCHEMBL4375598 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3636638-A1 | COMPOSITION COMPRISING AN IONIC LIQUID WITH FLUORINATED ANION | proionic GmbH (AT) | 2020-04-15 | — | — | EP | claimed |
| EP-3027293-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | ExxonMobil Research and Engineering Company (US) | 2016-06-08 | — | — | EP | claimed |
| WO-2015017240-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-02-05 | — | — | WO | claimed |
| US-20150027055-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-01-29 | — | — | US | claimed |
| US-20150027056-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-01-29 | — | — | US | claimed |
| WO-2012048411-A1 | PLK-4 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | UNIVERSITY HEALTH NETWORK (CA) | 2012-04-19 | — | — | WO | claimed |
| US-7897778-B2 | Benzamide compounds | ASTRAZENECA (SE) | 2011-03-01 | — | — | US | claimed |
| US-7745641-B2 | Nitrogen-containing heterocyclic compound | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-06-29 | — | — | US | claimed |
| US-20080293687-A1 | Benzamide Compounds | ASTRAZENECA AB (SE) | 2008-11-27 | — | — | US | claimed |
| US-20080221361-A1 | Ionic Liquids | BIONIQS LIMITED (GB) | 2008-09-11 | — | — | US | claimed |
| EP-1948589-A1 | IONIC LIQUIDS | Bioniqs Limited (GB) | 2008-07-30 | — | — | EP | claimed |
| WO-2007036712-A1 | IONIC LIQUIDS | BIONIQS LIMITED (GB) | 2007-04-05 | — | — | WO | claimed |
| WO-2006024841-A2 | BENZAMIDE COMPOUNDS | ASTRAZENECA AB (SE) | 2006-03-09 | — | — | WO | claimed |
| US-12053738-B2 | Process for increased selectivity and capacity for hydrogen sulfide capture from acid gases | ExxonMobil Technology and Engineering Company (US) | 2024-08-06 | — | — | US | disclosed |
| US-20240213479-A1 | ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, ALL-SOLID STATE SECONDARY BATTERY, AND MANUFACTURING METHODS FOR ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, AND ALL-SOLID STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| WO-2023178299-A1 | PRODRUGS OF GANAXOLONE | MARINUS PHARMACEUTICALS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-1994007869-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1994-04-14 | — | — | WO | disclosed |
| EP-0501693-A1 | Isoquinoline derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-4065560-A | Tetrahydro-2-(nitromethylene)-2H-1,3-thiazine insect control agents | SHELL OIL COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-3993648-A | Tetrahydro-2-(nitromethylene)-2H-1,3-thiazines | SHELL OIL COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293687-A1 | Benzamide Compounds | HDAC1, HDAC11, HDAC2 | PIK3CD 4035/4885CA12 2176/4885CA2 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.